, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否存在潜在的联邦证券法违规行为和/或对股东的信托责任违反情况：
NV5 Global, Inc. (NASDAQ: NVEE) 向 Acuren Corporation 的出售。根据拟议交易的条款，NV5 股东将在交易完成时每股获得约 23.00 美元，其中包括 10.00 美元现金和估计的 13.00 美元 Acuren 普通股。如果您是 NV5 股东， 请点击这里了解您的权利和选择 。
Carisma Therapeutics Inc. (NASDAQ: CARM) 与 OrthoCellix, Inc. 的合并。在拟议交易完成后，现有的 Carisma 股东预计将拥有合并公司约 10% 的股份。如果您是 Carisma 股东，请点击这里了解您的法律权利和选择。
Heliogen, Inc. (OTCQX: HLGN) 向 Zeo Energy Corp 的出售。在拟议交易完成时，Heliogen 的证券持有人将根据 Zeo Class A 普通股每股 1.5859 美元的价格，获得总价值约 1000 万美元的 Zeo Class A 普通股，并根据 Heliogen 在交易完成时的净现金情况进行调整。如果您是 Heliogen 股东， 请点击这里了解您的权利和选择 。
Halper Sadeh LLC 可能会寻求为股东增加对价、提供有关拟议交易的额外披露和信息，或代表股东寻求其他救济和利益。我们将以风险代理的方式处理此案，您无需承担我们的法律费用或支出的自付费用。
鼓励股东与该事务所 免费 联系，以讨论他们的法律权利和选择。请致电 Daniel Sadeh 或 Zachary Halper，电话 (212) 763-0060，或发送电子邮件至 [email protected] 或 [email protected]。
Halper Sadeh LLC 代表全球的投资者，帮助他们应对证券欺诈和公司不当行为。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
律师广告。以往的结果并不保证类似的结果。
联系信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
来源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNzE2Jk5ld3NJdGVtSWQ9TlkzMTU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNTA3MTYxMTMyUFJfTkVXU19VU1BSX19fX19OWTMxNTQy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNzE2Jk5ld3NJdGVtSWQ9TlkzMTU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNTA3MTYxMTMyUFJfTkVXU19VU1BSX19fX19OWTMxNTQy"/>

NVEE

HLGN

CARM

Halper Sadeh LLC 正在调查 NV5 Global, Inc. (NASDAQ: NVEE)、Carisma Therapeutics Inc. (NASDAQ: CARM) 和 Heliogen, Inc. (OTCQX: HLGN) 是否存在潜在的联邦证券法违规行为和对股东的信托责任违反。这些调查涉及 NV5 向 Acuren 的出售、Carisma 与 OrthoCellix 的合并以及 Heliogen 向 Zeo Energy Corp. 的出售。鼓励股东联系 Halper Sadeh LLC 以讨论他们在这些交易中的法律权利和选择

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
<div class="lb-trans">, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否存在潜在的联邦证券法违规行为和/或对股东的信托责任违反情况：
</div>NV5 Global, Inc. (NASDAQ: NVEE)'s sale to Acuren Corporation. Under the terms of the proposed transaction, NV5 shareholders will receive approximately $23.00 per share consisting of $10.00 in cash and an estimated $13.00 in shares of Acuren common stock at closing. If you are a NV5 shareholder, click here to learn more about your rights and options .
<div class="lb-trans">NV5 Global, Inc. (NASDAQ: NVEE) 向 Acuren Corporation 的出售。根据拟议交易的条款，NV5 股东将在交易完成时每股获得约 23.00 美元，其中包括 10.00 美元现金和估计的 13.00 美元 Acuren 普通股。如果您是 NV5 股东， 请点击这里了解您的权利和选择 。
</div>Carisma Therapeutics Inc. (NASDAQ: CARM)'s merger with OrthoCellix, Inc. Upon completion of the proposed transaction, existing Carisma shareholders are expected to own approximately 10% of the combined company. If you are a Carisma shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Carisma Therapeutics Inc. (NASDAQ: CARM) 与 OrthoCellix, Inc. 的合并。在拟议交易完成后，现有的 Carisma 股东预计将拥有合并公司约 10% 的股份。如果您是 Carisma 股东，请点击这里了解您的法律权利和选择。
</div>Heliogen, Inc. (OTCQX: HLGN)'s sale to Zeo Energy Corp. Upon closing of the proposed transaction, Heliogen's securityholders will receive shares of Zeo's Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share, and subject to an adjustment mechanism based on Heliogen's net cash at the closing. If you are a Heliogen shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Heliogen, Inc. (OTCQX: HLGN) 向 Zeo Energy Corp 的出售。在拟议交易完成时，Heliogen 的证券持有人将根据 Zeo Class A 普通股每股 1.5859 美元的价格，获得总价值约 1000 万美元的 Zeo Class A 普通股，并根据 Heliogen 在交易完成时的净现金情况进行调整。如果您是 Heliogen 股东， 请点击这里了解您的权利和选择 。
</div>Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">Halper Sadeh LLC 可能会寻求为股东增加对价、提供有关拟议交易的额外披露和信息，或代表股东寻求其他救济和利益。我们将以风险代理的方式处理此案，您无需承担我们的法律费用或支出的自付费用。
</div>Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
<div class="lb-trans">鼓励股东与该事务所 免费 联系，以讨论他们的法律权利和选择。请致电 Daniel Sadeh 或 Zachary Halper，电话 (212) 763-0060，或发送电子邮件至 [email protected] 或 [email protected]。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球的投资者，帮助他们应对证券欺诈和公司不当行为。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律师广告。以往的结果并不保证类似的结果。
</div>Contact Information:
<div class="lb-trans">联系信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">来源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNzE2Jk5ld3NJdGVtSWQ9TlkzMTU0MiZUcmFuc21pc3Npb25fSWQ9MjAyNTA3MTYxMTMyUFJfTkVXU19VU1BSX19fX19OWTMxNTQy" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY31542&amp;Transmission_Id=202507161132PR_NEWS_USPR_____NY31542&amp;DateId=20250716"/>

股东调查：Halper Sadeh LLC 代表股东对 NV5 Global、Carisma Therapeutics、Heliogen 进行调查